Skip to main content
v2026.11,986 entries · CC-BY 4.0

CRMP (CASRAI)

Clinical Research Associate Certification: Clinical Research Monitoring Professional, CRMP (CASRAI)

Examined CASRAI credential for practising monitors and sponsor oversight staff: risk-based monitoring, interim visits, escalation, CRO oversight, and EU, UK and US rules. Not the CCRA.

LevelProfessionalCRMCRMP (CASRAI)
6 h
Nominal
Self-paced study
12
Lessons
Self-paced
9
Domains
Exam blueprint
75
Exam items
Per attempt
70%
Pass mark
Fixed, uncurved
90
Retake wait
Days
3 yr
Valid for
From the pass

What you earn

The credential itself

Pass the examination and CASRAI issues this certificate and the post-nominal CRMP (CASRAI), signed by the Programme Director, valid for 3 years, and checkable by anyone from the verification code on its face.

Specimen. Issued as a signed PDF and as a machine-readable Open Badge; the holder and code shown are illustrative.
How it appears on your CV

Certifications

CRMP (CASRAI) — Clinical Research Monitoring, Professional

CASRAI·Issued Mar 2026·Credential ID CASRAI-CRM-2026-XQMTV0

casrai.org/verify/CASRAI-CRM-2026-XQMTV0

Every certificate is issued under the signature of Dr. Diana Nieves Castro, MD, Programme Director of CASRAI Certification, who sets the syllabus, blueprint and pass mark for this credential.

It certifies that its holder passed the CASRAI examination for this course on the date shown, scored against the blueprint and pass mark published on this page — and anyone can confirm it from the verification code, without an account and without contacting us.

About this credential

What it covers

Clinical Research Monitoring — Professional is an examined CASRAI credential for practising clinical research monitors and the sponsor staff who oversee monitoring. Holders use the designation CRMP (CASRAI). It is built on ICH E6(R3) Good Clinical Practice and also covers the monitoring, serious-breach and record-retention rules of the European Union, the United Kingdom and the United States.

CRMP (CASRAI) is not ACRP’s CCRA or SOCRA’s CCRP. It is not equivalent to either, is not endorsed by either body and does not count toward their eligibility requirements.

Who it is for

  • Clinical research associates and monitors with at least two years in the role, including those working for academic sponsors and on investigator-initiated trials
  • Lead and senior monitors who write monitoring plans, sampling rules and visit reports
  • Sponsor-side clinical operations and oversight staff who manage monitoring delivered by a CRO
  • Centralised monitoring, data review and medical monitoring staff who work alongside site monitors

The course assumes working knowledge of GCP and of routine site monitoring. Newer monitors can start with the Foundation tier, CRMF (CASRAI).

What you will be able to do

  • Explain where monitoring sits in ICH E6(R3) quality management and what changed from E6(R2)
  • Derive the extent and nature of monitoring from identified risks, and write the strategy, methods, rationale and sampling sections of a monitoring plan
  • Set quality tolerance limits and say what must happen when one is exceeded
  • Allocate work between centralised, remote and on-site monitoring, and adapt a plan for home visits, direct-to-participant shipment and digital health technologies
  • Assess a candidate site’s resources on evidence and confirm that a site is ready to enrol
  • Verify consent and eligibility from source, use audit trails, and adjust a verification sample when data quality is poor
  • Reconcile investigational product and safety data, and classify deviations and noncompliance, including noncompliance by the sponsor’s own staff
  • Apply the essential-records criteria and the EU and UK retention rules
  • Write a monitoring report and follow-up that lead to closure, escalate by the right route, and recognise when a problem needs an audit rather than more monitoring
  • Oversee a CRO without simply re-monitoring its sites, and route serious breaches and safety notifications correctly in the EU, the UK and the US

Modules

  1. Quality management, risk management and the R2→R3 transition
  2. Designing a risk-based monitoring strategy
  3. Centralised and remote monitoring
  4. Monitoring in decentralised settings
  5. Site selection, qualification and initiation
  6. Interim monitoring: eligibility, consent and source review
  7. Investigational product and safety reconciliation
  8. Deviations, noncompliance and corrective and preventive action
  9. Essential records, the trial master file and the investigator site file
  10. Reports, escalation and triggered monitoring
  11. Sponsor oversight of service providers
  12. The EU, UK and US frameworks compared

The exam

  • 75 scored multiple-choice questions per attempt, drawn from a larger bank in proportion to the published domain weights
  • Most questions are short monitoring scenarios that ask you to apply or analyse the rules; a smaller share test recall
  • Pass mark: 70%
  • Must be finished within 4 hours of starting.
  • You must complete every lesson before you can start the exam
  • If you do not pass, you can retake the exam after 90 days

Eligibility

The Foundation tier has no prerequisite. The Professional tier is for experienced practitioners. At checkout you confirm that you meet one of these routes; CASRAI does not ask for documents:

  • Experience: 24 months’ cumulative experience in the last 8 years in clinical trial monitoring or in sponsor-side oversight of monitoring. Part-time work counts pro rata.
  • Foundation plus experience: the CASRAI Clinical Research Monitoring Foundation credential, CRMF (CASRAI), plus 12 months of that experience.
  • Another credential plus experience: a current clinical research credential from another certifying body, plus 12 months of that experience.
  • Education plus experience: a completed degree or postgraduate certificate in clinical research, clinical trials or a closely related field, plus 12 months of that experience.

Paid and unpaid work both count, including contract and freelance work, academic-sponsor monitoring and investigator-initiated trials. Supervised placements and structured internships count for up to 6 of the 24 months. Completing courses does not count as experience.

What the credential is, and what it is not

  • It is an examined credential issued by CASRAI. Each certificate can be verified with CASRAI.
  • It is not accredited, and it carries no CE, CME or CEU credit.
  • It does not meet any statutory, funder, sponsor or institutional training requirement, including GCP training requirements.
  • It is not endorsed by any regulator, funder or professional body.
  • It is not a licence and gives no authority to monitor. A monitor’s authority comes from the sponsor that appoints them and from the trial agreements.

Validity and renewal

A CRMP (CASRAI) certificate is valid for 3 years from the date you pass. To renew it, you pass the current version of the exam again.

Price

US$279, paid once. The price covers the twelve-module course and the exam, and your course access does not expire.

Body of knowledge

Exam blueprint

The exam is assembled to these weights on every attempt. They are published before purchase because a blueprint you cannot see is not a blueprint.

Domains and weights9 domains · 75 scored items
DomainWeight
The monitoring obligation, quality management and the move from ICH E6(R2) to E6(R3)D1
12%9 items
Risk-based monitoring design: strategy, monitoring plan and quality tolerance limitsD2
14%11 items
Centralised, remote, on-site and decentralised monitoringD3
12%9 items
Site selection, qualification and initiationD4
10%8 items
Interim monitoring: consent, eligibility, source review and verificationD5
16%12 items
Investigational product, safety reconciliation, deviations and noncomplianceD6
12%9 items
Essential records, the trial master file and the investigator site fileD7
8%6 items
Monitoring reports, follow-up, escalation and for-cause activityD8
10%7 items
Oversight of CROs and other service providers; EU, UK and US requirements comparedD9
6%4 items
Total100%

Every attempt has this many items from each domain. The items themselves are drawn at random from the bank within those fixed per-domain quotas, so no two attempts are the same paper.

Syllabus

Syllabus: 12 lessons, 6 hours

Every lesson and every learning outcome is listed. The lesson bodies open on enrolment, and the exam opens once every lesson is marked complete.

12 lessons · 6.3 h

Lesson material opens once you are enrolled. The full syllabus and every learning outcome are shown here so you can judge the coverage before you pay.

  1. Lesson 1

    Module 1

    1 lesson · 30 min

    1. Locked.Quality management, risk management and the R2→R3 transition30 min · Locked

      On completion you will be able to

      • Locate monitoring within sections 3.10 and 3.11 of ICH E6(R3) and explain what that placement means for how monitoring is justified
      • Work the section 3.10.1 risk cycle for a supplied protocol, from risk identification to reporting in the clinical trial report
      • Distinguish monitoring, audit and inspection by purpose and independence for a given finding
      • Decide whether a named role may perform a monitoring activity under the section 3.11.4 involvement constraint
      • Brief a study team on the E6(R2) to E6(R3) changes that alter monitoring practice
  2. Lesson 2

    Module 2

    1 lesson · 30 min

    1. Locked.Designing a risk-based monitoring strategy30 min · Locked

      On completion you will be able to

      • Derive the extent and nature of monitoring for a supplied protocol from its identified risks and the section 3.11.4 factors
      • Draft the strategy, methods and rationale sections of a monitoring plan that meet section 3.11.4.3
      • Specify a verification sample and defend it to a site using section 3.11.4.5.4(b)
      • Set a quality tolerance limit and state the actions required when it is exceeded
      • Apply Article 48 of Regulation (EU) No 536/2014 to an EU trial and identify where it differs from ICH
  3. Lesson 3

    Module 3

    1 lesson · 30 min

    1. Locked.Centralised and remote monitoring30 min · Locked

      On completion you will be able to

      • Allocate a trial's monitoring activities across centralised, remote and on-site modalities and justify the allocation
      • Classify a described activity correctly as site monitoring (on-site or remote), centralised monitoring or audit
      • Interpret a centralised monitoring signal and decide whether and how it should trigger targeted site monitoring
      • Specify the access, authentication and confidentiality controls required for remote read-only source access
  4. Lesson 4

    Module 4

    1 lesson · 30 min

    1. Locked.Monitoring in decentralised settings30 min · Locked

      On completion you will be able to

      • Identify the decentralised elements in a supplied protocol using the Annex 2 definition
      • Determine which party is accountable for suitability and for oversight of a home-nursing or DHT service provider, and cite the basis
      • Adapt a monitoring plan so that it covers direct-to-participant shipment, home visits and DHT data
      • Specify the privacy and confidentiality safeguards needed when service providers handle participants' personal information
  5. Lesson 5

    Module 5

    1 lesson · 30 min

    1. Locked.Site selection, qualification and initiation30 min · Locked

      On completion you will be able to

      • Assess a candidate site against sections 3.7 and 2.2 and write a recommendation supported by evidence
      • Distinguish evidence of resources from assertions of resources in a feasibility response
      • Confirm in the section 3.11.4.5.2(b) sense whether a site and each delegated staff member are ready to start
      • Identify the agreement terms, including direct access, that must be in place before trial activities start
  6. Lesson 6

    Module 6

    1 lesson · 30 min

    1. Locked.Interim monitoring: eligibility, consent and source review30 min · Locked

      On completion you will be able to

      • Plan an interim monitoring activity from the monitoring plan's risk priorities rather than a generic checklist
      • Verify eligibility criterion by criterion from source and state what has and has not been established
      • Detect unreported events, medications and deviations in source records and identify the process failure behind them
      • Diagnose a consent defect and determine whether it can be remedied
      • Use an audit trail to establish the history of a change and decide what must still be checked
      • Adjust a verification sample when the first tranche shows a problem, and document the adjustment
  7. Lesson 7

    Module 7

    1 lesson · 30 min

    1. Locked.Investigational product and safety reconciliation30 min · Locked

      On completion you will be able to

      • Reconcile an investigational product accountability record and locate the break
      • Run a safety reconciliation between clinical and safety data and resolve each difference
      • Determine expectedness against the reference safety information and state the consequence of an out-of-date Investigator's Brochure
      • Check that blinding and randomisation safeguards have been maintained at a site
  8. Lesson 8

    Module 8

    1 lesson · 30 min

    1. Locked.Deviations, noncompliance and CAPA input30 min · Locked

      On completion you will be able to

      • Classify a deviation as important or not against a sponsor's section 3.9.3 criteria
      • Distinguish deviation, noncompliance and serious noncompliance and route each correctly
      • Recognise noncompliance by the sponsor's own staff and state what section 3.12 requires
      • Critique a CAPA record and supply monitoring evidence to a root cause analysis without performing it
  9. Lesson 9

    Module 9

    1 lesson · 45 min

    1. Locked.Essential records, TMF and ISF45 min · Locked

      On completion you will be able to

      • Apply the Appendix C.3.1 criteria to decide whether a record that appears on no list is essential
      • Assess whether a site's records meet Appendix C.2.6 and rank gaps by seriousness
      • Decide who should hold an original record and when a copy may replace it
      • Determine the retention obligation for a trial master file in the EU and the UK and its source
      • Express a file finding against E6(R3) requirements rather than against a vendor's file model
  10. Lesson 10

    Module 10

    1 lesson · 30 min

    1. Locked.Reports, escalation and triggered monitoring30 min · Locked

      On completion you will be able to

      • Write a monitoring report that meets every element of section 3.11.4.6(a), including carry-forward of unresolved items
      • Write a follow-up letter that produces closure evidence rather than acknowledgement
      • Escalate a finding by the correct route and with the correct urgency, including an immediate hazard
      • Plan a triggered monitoring activity and identify the point at which it should instead be an audit
      • State what a monitor must and must not do when data manipulation is suspected
  11. Lesson 11

    Module 11

    1 lesson · 30 min

    1. Locked.Sponsor oversight of service providers30 min · Locked

      On completion you will be able to

      • Write the oversight section of a monitoring plan for a trial whose monitoring is delivered by a CRO
      • Design oversight activities that test the service provider's processes rather than repeat its monitoring
      • Determine which party holds an activity that a transfer agreement does not allocate
      • Assess whether a provider's existing quality system is fit for purpose for the trial
  12. Lesson 12

    Module 12

    1 lesson · 30 min

    1. Locked.The national frameworks compared30 min · Locked

      On completion you will be able to

      • Route a serious breach correctly in the EU and the UK, with the recipient and the deadline
      • State the EU notification deadlines for unexpected benefit-risk events and urgent safety measures
      • Apply the US drug and device rules at 21 CFR 312.56(d) and 812.46(b)(2) to a risk determination
      • Distinguish a serious breach from serious noncompliance and from an important protocol deviation
      • Describe the MHRA inspection grading and identify national requirements with no ICH equivalent

Assessment

How the exam works

The exam is closed-book and multiple choice. Each attempt draws a fresh form to the domain weights above, so no two attempts are the same paper and no answer key circulates. The pass mark is 70% and is fixed — there is no curve, no quota and no adjustment by cohort.

Scoring is immediate. Pass, and every item is reviewed with the option you chose, the correct option and its rationale. If you do not pass, you see your overall score and your score per domain (smaller domains are grouped together); which items you missed, and their answers, are held back so your resit is still a real assessment. A failed attempt may be retaken after 90 days. The wait exists so a retake is a second attempt at the material rather than a second attempt at remembering the paper.

The exam opens once you have marked every lesson of the course complete. Forms are assembled to the blueprint above or not at all: where a domain cannot yet be sampled to that standard, the exam declines to start rather than issue an unbalanced paper. Your material and progress are never affected, and there is no time limit on when you sit.

Passing candidates are issued a certificate with a verification code, valid for 3 years from the date of the pass. Anyone can check that code on our public verification page without an account and without contacting us. To renew, pass the current examination again: renewal opens 180 days before the certificate expires, and a pass issues a renewed certificate valid for a further 3 years from that date.

Certifying authority

Signed by Dr. Diana Nieves Castro, MD

CASRAI’s certification programme is academically and medically directed by Dr. Diana Nieves Castro, MD, Programme Director, who sets the syllabus and blueprint for this credential and signs every certificate issued under it.

CASRAI has maintained the terminology and reporting standards of research administration for over a decade. It assumed leadership of the CRediT contributor-roles taxonomy in 2014 and carried it through to adoption as ANSI/NISO Z39.104-2022, now in use by publishers, funders and institutions worldwide. This examination is drawn from that body of work.

What the credential certifies: that its holder passed the CASRAI examination for this course on the date shown, scored against the blueprint and pass mark published above. It is valid for 3 years, and anyone can check it from the verification code on its face.

The ladder

Other levels of Clinical Research Monitoring

Levels are independent purchases. There is no prerequisite chain — sit whichever level matches the work you already do.

All CASRAI credentials

Common questions

Clinical Research Associate Certification: Clinical Research Monitoring Professional, CRMP (CASRAI): common questions

How to get clinical research associate certification?

Monitors usually look at the established credentials, ACRP's CCRA and SOCRA's CCRP, and should check each body's own eligibility rules. CRMP (CASRAI) is a separate credential issued by CASRAI: you confirm at checkout that you meet one of its experience routes, complete all 12 lessons, then pass a 75-item online multiple-choice exam with a score of 70% or higher.

SOCRA vs ACRP certification: what is the difference?

ACRP awards the CCRA, a credential for clinical research associates, and SOCRA awards the CCRP; each body sets its own eligibility, exam and recertification rules, so compare them on their official pages. CRMP (CASRAI) is neither: it is not equivalent to either credential, is not endorsed by either body and does not count toward their eligibility requirements.

How much does clinical research associate certification cost?

Clinical Research Monitoring Professional costs US$279, paid once by card through Stripe checkout. The price covers the twelve-lesson course and the CRMP (CASRAI) exam, and course access does not expire.

What does the CRMP (CASRAI) exam cover?

Each attempt has 75 four-option multiple-choice items drawn from the course bank across nine weighted domains, led by interim monitoring (consent, eligibility, source review and verification, 16%) and risk-based monitoring design with quality tolerance limits (14%). The exam is taken online, is not proctored and must be completed within 4 hours of starting. The pass mark is 70%, and after a failed attempt you can retake it after a 90-day waiting period.

How long is the CRMP (CASRAI) certificate valid?

A CRMP (CASRAI) certificate is valid for 3 years. You renew it by passing the current exam again, and the renewal window opens 180 days before expiry. Each certificate has a public verification page on casrai.org, reached through the certificate’s verification code.

Does CRMP (CASRAI) count toward CCRA certification requirements?

No. It does not count toward ACRP's or SOCRA's eligibility requirements and is not equivalent to the CCRA or the CCRP. It is evidence of examined knowledge, not a licence or an authority to monitor. Newer monitors can start with the Foundation tier, CRMF (CASRAI).

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →